» Articles » PMID: 31820694

Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI)

Overview
Journal Curr Pharm Des
Date 2019 Dec 11
PMID 31820694
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Contrast-induced acute kidney injury (CIAKI) is a severe complication associated with the use of iodinated contrast media (CM); a sudden but potentially reversible fall in glomerular filtration rate (GFR) typically occurring 48-72 hours after CM administration. Principal risk factors related with the presentation of CIAKI are preexisting chronic kidney disease and diabetes mellitus. Studies on CIAKI present considerable complexity because of differences in CM type and dose, controversies in definition and baseline comorbidities. Despite that, it should be noted that CIAKI poses a serious health problem because it is a very common cause of hospitalacquired AKI, linked to increased morbidity and mortality and utilizing growing healthcare resources. The pathogenesis of CIAKI is heterogeneous and, thus, is incompletely understood. Three basic mechanisms appear to simultaneously occur for CIAKI development: Renal vasoconstriction and medullary hypoxia, tubular cell toxicity and reactive oxygen species formation. The relative contribution of each one of these mechanisms is unknown but they ultimately lead to epithelial and endothelial cell apoptosis and GFR reduction. Further research is needed in order to better clarify CIAKI pathophysiology and accordingly introduce effective preventive and therapeutic strategies.

Citing Articles

Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis.

Wang X, Han S, Zhao L, Cong H Sci Rep. 2024; 14(1):32074.

PMID: 39738496 PMC: 11686283. DOI: 10.1038/s41598-024-83741-5.


Risk Score for Predicting AKI from Contrast-Enhanced CT (Pre-CT AKI score): Training and Validation from Retrospective Cohort.

Pattharanitima P, Bumrungsong N, Phoompho B, Tanin R, Anumas S Kidney360. 2024; .

PMID: 39418104 PMC: 11793181. DOI: 10.34067/KID.0000000623.


[Biomarkers of oxidative stress and inflammation in contrast-associated acute kidney injury].

Stoll E, Monedero P, Martin-Moreno P, Garcia-Fernandez N An Sist Sanit Navar. 2024; 47(2).

PMID: 39104332 PMC: 11361282. DOI: 10.23938/ASSN.1081.


CUX1 attenuates the apoptosis of renal tubular epithelial cells induced by contrast media through activating the PI3K/AKT signaling pathway.

Yue R, Wang J, Lin F, Li C, Su B, Zeng R BMC Nephrol. 2024; 25(1):192.

PMID: 38849771 PMC: 11162042. DOI: 10.1186/s12882-024-03625-8.


Prevention of contrast-associated acute kidney injury in an era of increasingly complex interventional procedures.

Somkereki C, Palfi R, Scridon A Front Med (Lausanne). 2024; 10:1180861.

PMID: 38264052 PMC: 10803418. DOI: 10.3389/fmed.2023.1180861.